Population proteomics: the concept, attributes, and potential for cancer biomarker research (Q36492806)

14 August 2017

1 reference

title

Population proteomics: the concept, attributes, and potential for cancer biomarker research (English)

1 reference

14 August 2017

0 references

Dobrin Nedelkov

1

1 reference

14 August 2017

Urban A Kiernan

2

1 reference

14 August 2017

Eric E Niederkofler

3

1 reference

14 August 2017

Kemmons A Tubbs

4

1 reference

14 August 2017

Randall W Nelson

5

1 reference

14 August 2017

publication date

30 May 2006

1 reference

Molecular & Cellular Proteomics

14 August 2017

published in

1 reference

14 August 2017

volume

5

1 reference

14 August 2017

issue

10

1 reference

14 August 2017

page(s)

1811-1818

1 reference

Clinical proteomics: translating benchside promise into bedside reality

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Clinical proteomics for cancer biomarker discovery and therapeutic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Current developments in SELDI affinity technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Proteomic applications for the early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Clinical proteomics: revolutionizing disease detection and patient tailoring therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Lessons from Kitty Hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Clinical proteomics and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

A data review and re-assessment of ovarian cancer serum proteomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Lessons from controversy: ovarian cancer screening and serum proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identificati

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Progress in protein and antibody microarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Functional protein microarrays: ripe for discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

SPR for molecular interaction analysis: a review of emerging application areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Differences among techniques for high-abundant protein depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Probe-immobilized affinity chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Mass spectrometric immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Characterization of transthyretin mutants from serum using immunoprecipitation, HPLC/electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Detection and quantification of beta-2-microglobulin using mass spectrometric immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

High-throughput protein characterization using mass spectrometric immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Proteomic characterization of novel serum amyloid P component variants from human plasma and urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Quantitative mass spectrometric immunoassay of insulin like growth factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Comparative Urine Protein Phenotyping Using Mass Spectrometric Immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Detection of novel truncated forms of human serum amyloid A protein in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Investigating diversity in human plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

The International HapMap Project Web site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

High-throughput comprehensive analysis of human plasma proteins: a step toward population proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Population proteomics: addressing protein diversity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Population proteomics: an emerging discipline to study metapopulation ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Differential exoprotease activities confer tumor-specific serum peptidome patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Diagnosis of congenital disorders of glycosylation type-I using protein chip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Comparative phenotypic analyses of human plasma and urinary retinol binding protein using mass spectrometric immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

A proteolytic NH2-terminal truncation of cardiac troponin I that is up-regulated in simulated microgravity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Serum proteomics profiling—a young technology begins to mature

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Proteomic patterns to identify ovarian cancer: 3 years on

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

Tabulation of human transthyretin (TTR) variants, 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

An on-line assay for clinical detection of amyloidogenic transthyretin variants directly from serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R600006-MCP200

10.1074/MCP.R600006-MCP200

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference